39 ST companies 70% rely on restructuring shell problem frequently, a number of enterprises were ask-boee

39 *ST, 70% by recombinant Paul shell companies were more frequent problems: App live on-line inquiries Sina blogger to tutor the purchase of new shares: the stock market is the most simple way to pick up the money – this reporter in the "11" National Day is approaching, a delisting crisis *ST company have been tense for Paul shell at the end of the war. Flush according to statistics, at present, there are 39 *ST companies are likely the risk of suspension of listing; 16 *ST companies have fled; 10 *ST companies have 6 *ST companies unchanged; uncertainty; 2 *ST companies have 1 stars; *ST stars is 1 *ST with the company; the conditions. According to the incomplete statistics of the Securities Daily reporter, it is found that over 70% of the listed companies have adopted the method of reorganization to protect the shell in the process of shell keeping of the 39 *ST companies; and nearly 20% of the listed companies have taken the way of selling assets to protect the shell. Among them, *ST Ning B is more famous for selling two schools in Beijing. For *ST listed companies at any price to protect the shell behavior, there are market analysts, under the new regulations, "shell" resource speculation will cool substantially in the short term, "shell" resources shrink the value of *ST listed companies to protect the shell more difficult. In the three quarter restructuring held most close to ending at the same time, from the end of 2016, only more than 3 months, up to now, there are 39 companies *ST if the poor performance in 2016 would risk suspended the listing. In order to prepare for the Paul shell, the *ST company once again resorted to reorganization of magic. Only one month of September estimates, including *ST and *ST have biological Jianfeng, *ST, *ST in the Pearl River and other companies announced the restructuring related announcement related. It is worth noting that a number of restructuring companies have been questioned by the exchange, and the listed companies have also responded to inquiries. Among them, *ST biological disclosure of the major asset restructuring draft shows that the company will divest news and publishing business, based on the original biological medicine to increase energy saving technology services industry. In the face of the *ST biological reorganization plan, the Shenzhen Stock Exchange from the purchase of assets of the source of funds, the target assets, city light energy purchasing concentration higher than 80% and other aspects of the inquiry. In this regard, *ST biological reply said, the city of light energy upstream suppliers within the industry, a large number of production enterprises, sufficient market supply, there is no dependence on a single supplier or insufficient supply risk. In the aspect of engineering service provision, there are many construction enterprises, and there is no risk of relying on single supplier or insufficient supply. Similarly, *ST Jianfeng plans to purchase the Chongqing pharmaceutical reorganization plan, recently received the Shenzhen Stock Exchange restructuring inquiry letter, the complex history of the transaction target, especially the stock holding, cross shareholdings, investment defects and other issues received the focus of attention. It is worth noting that *ST Hongsheng August 27th announcement from the SSE restructuring letter of inquiry, enquiry on the restructuring of the purpose of the transaction, the company set out the assets, in the target company, counterparties and other aspects of the question. Because of the *ST statement

39家*ST公司七成靠重组保壳 问题频出多家企业遭问询 新浪财经App:直播上线 博主一对一指导 新股申购:股市最简单捡钱方式   ■本报记者 矫 月   在“十一”国庆即将来临之际,有着退市危机的*ST公司也纷纷紧张备战年底的保壳之战。据同花顺统计数据显示,目前,有39家*ST公司存在有可能暂停上市的风险;16家*ST公司有可能摘帽;10家*ST公司可能不变;6家*ST公司不确定;2家*ST公司有可能摘星;1家*ST公司即将摘星;1家*ST公司符合摘帽条件。   据《证券日报》记者不完全统计发现,在上述39家*ST公司保壳过程中,有逾七成的上市公司采取了重组的方式保壳;另有近两成的上市公司采取卖资产的方式保壳。其中,*ST宁通B更是因为卖出北京两套学区房增收而出名。   对于*ST上市公司不惜代价的保壳行为,有市场人士分析,在新规下,“壳”资源炒作短期内将大幅降温,“壳”资源的价值缩水造成*ST上市公司保壳难度加大。   重组大戏开锣   在三季度临近收官的同时,距离2016年年底,仅余3个月的时间,而截至目前,有39家*ST公司如果在2016年表现不佳的话将存在被暂停上市的危险。   为了备战保壳,上述*ST公司再次祭出重组法宝。仅仅估算9月份一个月,就有包括*ST生物、\*ST建峰、*ST中企、*ST珠江等多家公司公布与重组有关的相关公告。值得注意的是,有多家公司的重组遭到交易所问询,而上市公司也针对问询进行了相关回复。   其中,*ST生物披露的重大资产重组草案显示,公司将剥离新闻和出版业务,在原有生物医药的基础上增加节能技术服务行业。面对*ST生物此次重组预案,深交所从购买资产的资金来源、标的资产城光节能采购集中度高于80%等方面提出了问询。   对此,*ST生物回复称,城光节能的上游供应商所属行业内生产企业众多,市场供应充足,不存在依赖单一供应商或者供给不足的风险。在工程服务提供方面,施工企业众多,也不存在依赖单一供应商或者供给不足的风险。   同样,*ST建峰拟购重庆医药的重组方案于近日收到深交所的重组问询函,交易标的复杂的历史沿革,尤其是股份代持、交叉持股、出资瑕疵等问题受到重点关注。   值得注意的是,*ST宏盛8月27日公告收到上交所重组问询函,问询函围绕公司此次重组交易的目的、置出标的资产、置入标的公司、交易对手等多方面进行提问。由于*ST宏盛此前曾有多次筹划重大事项失败的经历,且此次重组停牌过程冗长并发生过更换标的的情况,监管部门要求公司补充说明是否存在重组终止的风险,并且结合“保壳”背景,要求公司就此次交易目的作出更详细的披露。   此外,如*ST南电A、\*ST东晶、*ST珠江、\*ST兴化、\*ST钒钛、\*ST济柴等公司也皆曾收到来自交易所的重组问询函,还有存在不确定性的*ST江泉也曾因控制权问题受到上交所的两度问询。   据了解,在沪深交易所发出的问询函中,上市公司并购重组的转型风险、标的公司行业位置、财务情况、交易安排及其合理性以及专业机构意见几乎是重组类问询函“标配问题”。另外,并购重组标的估值作价情况、后续业绩保证措施也受到交易所关注。   对此,有业内人士提醒投资者,今年史上最严厉的重组新规实行,对于ST公司的保壳大战是个考验,一旦触及现有法规,即会受到监管层关注,其股价也会出现大幅波动,投资者炒作该板块要防雷。   “卖房”不只*ST宁通B一家   面临暂停上市的危机,上市公司除了通过重组的途径来保壳外,还有部分公司通过“卖房”等拍卖资产的方式保壳。   其中,*ST瓦轴B早在2014年就曾动念拍卖房产,并在当年的股东大会上审议并通过了关于拟挂牌出售销售公司沈阳经销处房屋、哈尔滨经销处房屋的议案。但由于市场价格波动等原因,上述两处房屋未能完成出售,在大连市产权交易所挂牌后流拍。   公告显示,2015公司重新对上述两处房屋进行评估,两处房屋重新评估价值分别为1535.53万元和486.79万元,总计2022.32万元,经公司六届八次董事会审议通过后继续挂牌出售。而据公告显示,沈阳经销处房屋已打折出售给公司大股东。   除房产外,*ST景谷则拟对外转让部分自有活立木存货资产。公告显示,公司此次拟转让的活立木价值预计不超过7000万元,公司将通过对外刊登广告等方式公开征集受让方。据悉,*ST景谷此番拟转让的活立木主要为人工思茅松林,地处云南省普洱市景谷县碧安乡、永平镇、益智乡境内,总采伐面积约5.5万亩(约占公司原料林基地的12.79%),综合蓄积量约36万立方米。   相比上述资产,*ST钒钛的卖出资产则更为值钱。公司拟向控股股东攀钢集团折价出售攀钢矿业100%股权、攀港公司70%股权、海绵钛项目以及鞍千矿业100%股权、鞍钢香港100%股权、鞍澳公司100%股权,上述股权总作价高达89.41亿元。   在*ST公司为保壳而采取的一系列拍卖资产的行动中,\*ST山煤以7元的便宜价格转让7家子公司的行为最为奇葩。   据*ST山煤公告显示,公司拟转让其所持的7家亏损子公司股权,7家公司全部股权作价7元,转让标的包括大同公司、大同经营公司、阳泉公司、朔州公司、通海煤焦、晋鲁公司和连云港公司7家全资子公司100%的股权,7家标的公司各按1元作价。公司称,交易标的长期亏损,严重拖累公司整体效益,2015年合计亏损约为8亿元,截至目前亏损仍在持续,此次交易有利于公司大额减亏。 进入【新浪财经股吧】讨论相关的主题文章:

Comments are closed.